Core Viewpoint - The announcement reveals that Huang Qianyi, a major shareholder of Huili Pharmaceutical, will passively reduce his shareholding due to a court's enforcement ruling, which mandates the forced sale of 1,300,000 shares [1][2] Group 1: Shareholder Reduction Plan - Huang Qianyi plans to reduce his holdings from February 3, 2026, to May 3, 2026, through centralized bidding, with a potential reduction of up to 1,300,000 shares, representing 0% to 0.307% of the company's total share capital [1] - The reduction is a result of judicial enforcement, and the shares involved are all unrestricted circulating shares [1] Group 2: Shareholder Information - As of the announcement date, Huang Qianyi holds 27,219,439 shares, accounting for 6.426% of Huili Pharmaceutical's total share capital [1] - Huang Qianyi is identified as the second-largest shareholder of Huili Pharmaceutical [2] Group 3: Company Background - Huili Pharmaceutical was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on October 26, 2021, with an initial public offering of 63.6 million shares at a price of 38.87 yuan per share [2] - The total funds raised from the IPO amounted to 2.472 billion yuan, with a net amount of 2.361 billion yuan after deducting issuance costs [3] - The company plans to use the raised funds for the construction of an EU-standard injection production base and an innovative drug research institute, as well as to supplement working capital [3]

Core Viewpoint - The company announced that major shareholder Yang Jianxin and his concerted party Xinyu Ruijing will be forced to dispose of a portion of their shares due to a dispute over a securities repurchase contract, which may impact the stock price and investor sentiment [1] Group 1 - Yang Jianxin and Xinyu Ruijing hold more than 5% of the company's shares and will be subject to forced execution of their holdings [1] - The forced disposal will involve a maximum of 15,477,425 shares, representing 1% of the company's total shares, excluding those in the company's repurchase account [1] - The shares will be disposed of through a centralized bidding method within three months after the announcement, starting from 15 trading days post-announcement [1]